Samalin Investment Counsel, LLC Teva Pharmaceutical Industries LTD Transaction History

Samalin Investment Counsel, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $34,300 - $59,750	-5,000 Reduced 31.77%	10,738 $87,000
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $3,859 - $5,439	523 Added 3.44%	15,738 $118,000
Q1 2022 Oct 13, 2022	SELL	$7.33 - $9.39 $25,655 - $32,865	-3,500 Reduced 18.7%	15,215 $143,000
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $25,655 - $32,865	-3,500 Reduced 18.7%	15,215 $143 Million
Q4 2021 Oct 13, 2022	BUY	$7.9 - $10.19 $23,518 - $30,335	2,977 Added 18.92%	18,715 $150,000
Q4 2021 Feb 15, 2022	BUY	$7.9 - $10.19 $79,000 - $101,900	10,000 Added 114.74%	18,715 $150 Million
Q2 2021 Aug 12, 2021	BUY	$9.9 - $11.56 $86,278 - $100,745	8,715 New	8,715 $86,000
Q1 2021 May 11, 2021	SELL	$10.34 - $12.81 $88,975 - $110,230	-8,605 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$8.61 - $11.04 $861 - $1,104	-100 Reduced 1.15%	8,605 $83 Million
Q3 2020 Nov 10, 2020	BUY	$8.57 - $12.69 $74,601 - $110,466	8,705 New	8,705 $78,000
Q1 2020 May 04, 2020	SELL	$6.69 - $13.45 $54,222 - $109,012	-8,105 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$6.53 - $10.72 $52,925 - $86,885	8,105 New	8,105 $79,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.